- Report
- January 2026
- 181 Pages
Global
From €3885EUR$4,500USD£3,365GBP
- Report
- January 2026
- 365 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 386 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 374 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 280 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 282 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 193 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 441 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- January 2026
- 173 Pages
Global
From €5050EUR$5,850USD£4,375GBP
- Report
- August 2025
- 150 Pages
Global
From €3452EUR$3,999USD£2,991GBP
- Report
- July 2025
- 350 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- June 2025
- 400 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- June 2025
- 400 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- June 2025
- 400 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- July 2025
- 350 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- June 2025
- 400 Pages
Global
From €4272EUR$4,949USD£3,701GBP
- Report
- September 2025
- 150 Pages
Global
From €3323EUR$3,850USD£2,879GBP
€4187EUR$4,850USD£3,627GBP
- Report
- June 2025
- 190 Pages
Global
From €4312EUR$4,995USD£3,736GBP
- Report
- May 2025
- 82 Pages
Global
From €3500EUR$4,343USD£3,138GBP
- Report
- May 2025
- 206 Pages
Global
From €4312EUR$4,995USD£3,736GBP

The Autoimmune Disease market within the context of Allergy and Immunology is a rapidly growing field of medical research and treatment. Autoimmune diseases are caused by an overactive immune system, which leads to the body attacking its own healthy cells and tissues. Common autoimmune diseases include rheumatoid arthritis, lupus, multiple sclerosis, and type 1 diabetes. Treatment for autoimmune diseases typically involves immunosuppressive drugs, which reduce the activity of the immune system, and biologics, which target specific parts of the immune system.
In recent years, the development of new treatments for autoimmune diseases has been a major focus of research and development in the Allergy and Immunology field. Companies in this market are focused on developing new treatments, such as monoclonal antibodies, small molecule drugs, and gene therapies. Examples of companies in this market include AbbVie, Amgen, Biogen, Celgene, Gilead, and Regeneron. Show Less Read more